Swedish Orphan Biovitrum AB (GB:0MTD)
LSE:0MTD
Holding GB:0MTD?
Track your performance easily

Swedish Orphan Biovitrum AB (0MTD) Financial Statements

1 Followers

Swedish Orphan Biovitrum AB Financial Overview

Swedish Orphan Biovitrum AB's market cap is currently ―. The company's EPS TTM is kr10.301; its P/E ratio is 31.57; Swedish Orphan Biovitrum AB is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is kr2.92. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuekr 5.99Bkr 4.00Bkr 3.88Bkr 4.92Bkr 4.90B
Gross Profitkr 4.68Bkr 3.07Bkr 2.86Bkr 3.41Bkr 3.88B
EBITkr 1.88Bkr 699.00Mkr 323.00Mkr 776.00Mkr 1.51B
EBITDAkr 2.47Bkr 1.28Bkr 888.00Mkr 1.46Bkr 2.04B
Net Income Common Stockholderskr 1.39Bkr 451.00Mkr 258.00Mkr 543.00Mkr 1.24B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 1.36Bkr 288.00Mkr 360.00Mkr 1.06Bkr 1.04B
Total Assetskr 52.50Bkr 50.93Bkr 48.43Bkr 48.81Bkr 48.66B
Total Debtkr 9.10Bkr 10.18Bkr 9.85Bkr 9.77Bkr 10.91B
Net Debtkr 7.74Bkr 9.89Bkr 9.49Bkr 8.71Bkr 9.86B
Total Liabilitieskr 25.97Bkr 25.87Bkr 24.10Bkr 25.05Bkr 25.46B
Stockholders Equitykr 26.52Bkr 25.07Bkr 24.33Bkr 23.76Bkr 23.20B
Cash Flow-
Free Cash Flowkr 1.83Bkr 56.00Mkr -191.00Mkr 1.49Bkr 1.88B
Operating Cash Flowkr 1.90Bkr 780.00Mkr 343.00Mkr 1.64Bkr 2.12B
Investing Cash Flowkr -63.00Mkr -724.00Mkr -533.00Mkr -157.00Mkr -245.00M
Financing Cash Flowkr -776.00Mkr -174.00Mkr -550.00Mkr -1.49Bkr -1.05B
Currency in SEK

Swedish Orphan Biovitrum AB Earnings and Revenue History

Swedish Orphan Biovitrum AB Debt to Assets

Swedish Orphan Biovitrum AB Cash Flow

Swedish Orphan Biovitrum AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis